UNITED ORTHOPEDIC CORPORATION United Orthopedic Corporation Stock
Equities
4129
TW0004129002
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.5 TWD | +0.50% |
|
+0.50% | +18.10% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 4.77B 147M | Sales 2025 * | - | Capitalization | 9.7B 300M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.03 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
4.98% | Yield 2025 * |
-
| Free-Float | 89.41% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.50% | ||
| 1 week | +0.50% | ||
| Current month | +0.50% | ||
| 1 month | +2.24% | ||
| 3 months | +4.58% | ||
| 6 months | +46.72% | ||
| Current year | +18.10% |
1 week
99.20
102.00
1 month
91.00102.00
Current year
82.80110.00
1 year
58.00110.00
3 years
27.50110.00
5 years
25.50110.00
10 years
25.50110.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yan Sheng Lin
CEO | Chief Executive Officer | - | 93-03-04 |
Yuan Chang Teng
DFI | Director of Finance/CFO | - | 16-10-02 |
Fang Yuan Ho
CTO | Chief Tech/Sci/R&D Officer | - | 16-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hai Yan Hao
BRD | Director/Board Member | - | 97-05-14 |
Yan Sheng Lin
CEO | Chief Executive Officer | - | 93-03-04 |
Chih Hsien Huang
BRD | Director/Board Member | - | 14-06-22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 100.5 | +0.50% | 896 783 |
| 24-05-07 | 100 | -0.99% | 874,984 |
| 24-05-06 | 101 | +1.00% | 644,753 |
| 24-05-03 | 100 | 0.00% | 760,267 |
| 24-05-02 | 100 | 0.00% | 522,954 |
End-of-day quote Taipei Exchange, May 07, 2024
More quotes
United Orthopedic Corporation is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of joint prosthesis products. The Companyâs main products consist of artificial hip joints, artificial knee joints, internal fixation of spines, orthopedic internal fixation of nails, bony plates, bony nails, osseous pins, bony screws and others. The Company distributes its products in Taiwan, the rest of Asia, the Americas, Europe and Africa markets.
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
100.5
TWD
Average target price
126
TWD
Spread / Average Target
+25.37%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +18.10% | 298M | |
| +9.52% | 127B | |
| -6.58% | 10.91B | |
| +2.70% | 9.24B | |
| -20.54% | 7.44B | |
| +34.56% | 5.44B | |
| +8.34% | 3.44B | |
| -8.96% | 2.87B | |
| -5.57% | 2.25B | |
| -0.60% | 2.23B |
- Stock Market
- Equities
- 4129 Stock